Curcumin-loaded silica-based mesoporous materials: Synthesis, characterization and cytotoxic properties against cancer cells

Materials Science and Engineering C

Volumn 63, Issue , 2016, Pages 393-410

  Bollu, Vishnu Sravan ^a,d   Barui, Ayan Kumar ^a,d   Mondal, Sujan Kumar ^a,d   Prashar, Sanjiv ^b   Fajardo, Mariano ^b   Briones, David ^c   Rodríguez Diéguez, Antonio ^c   Patra, Chitta Ranjan ^a,d   Gómez Ruiz, Santiago ^b  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

^d ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

Author keywords

Anti cancer; Curcumin; Cytotoxicity; Mesoporous silica materials; Nanomedicine

Indexed keywords

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; CELL CULTURE; CELL DEATH; CELLS; CHARACTERIZATION; CYTOLOGY; CYTOTOXICITY; DISEASES; MEDICAL NANOTECHNOLOGY; SILICA;

ANTI-CANCER; CURCUMIN; HUMAN BREAST CANCER CELLS; HUMAN LUNG CARCINOMA CELLS; MESOPOROUS SILICA MATERIALS; PHYSICOCHEMICAL TECHNIQUES; REACTIVE OXYGEN SPECIES; SILICA-BASED MESOPOROUS MATERIALS;

MESOPOROUS MATERIALS;

ANTINEOPLASTIC AGENT; CURCUMIN; DRUG CARRIER; MCM-41; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE;

A-549 CELL LINE; ANIMAL; APOPTOSIS; CELL MOTION; CHEMISTRY; DRUG EFFECTS; FLOW CYTOMETRY; HUMAN; MCF-7 CELL LINE; MOUSE; NANOMEDICINE; POROSITY; TUMOR CELL LINE; WESTERN BLOTTING;

A549 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CURCUMIN; DRUG CARRIERS; FLOW CYTOMETRY; HUMANS; MCF-7 CELLS; MICE; NANOMEDICINE; POROSITY; REACTIVE OXYGEN SPECIES; SILICON DIOXIDE;

EID: 84960444939     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2016.03.011     Document Type: Article

References (55)

1. T. Efferth, P.C. Li, V.S. Konkimalla, and B. Kaina From traditional Chinese medicine to rational cancer therapy Trends Mol. Med. 13 2007 353 361
2. H. Zhou, C.S. Beevers, and S. Huang The targets of curcumin Curr. Drug Targets 12 2011 332 347
3. R.K. Maheshwari, A.K. Singh, J. Gaddipati, and R.C. Srimal Multiple biological activities of curcumin: a short review Life Sci. 78 2006 2081 2087
4. A. Noorafshan, and S. Ashkani-Esfahani A review of therapeutic effects of curcumin Curr. Pharm. Des. 19 2013 2032 2046
5. H. Hatcher, R. Planalp, J. Cho, F.M. Torti, and S.V. Torti Curcumin: from ancient medicine to current clinical trials Cell. Mol. Life Sci. 65 2008 1631 1652
6. G. Bar-Sela, R. Epelbaum, and M. Schaffer Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications Curr. Med. Chem. 17 2010 190 197
7. T. Tanaka Colorectal carcinogenesis: review of human and experimental animal studies J. Carcinog. 8 2009 5
8. S. Hatamie, O. Akhavan, S.K. Sadrnezhaad, M.M. Ahadian, M.M. Shirolkar, and H.Q. Wang Curcumin-reduced graphene oxide sheets and their effects on human breast cancer cells Mater. Sci. Eng. C 55 2015 482 489
9. P. Anand, A.B. Kunnumakkara, R.A. Newman, and B.B. Aggarwal Bioavailability of curcumin: problems and promises Mol. Pharm. 4 2007 807 818
10. Z. Minpeng, and L. Suhong The stability of curcumin and drug-loading property of starch microspheres for it Adv. Biomed. Eng. 9 2012 44 48
11. L. Zhongfa, M. Chiu, J. Wang, W. Chen, W. Yen, P. Fan-Havard, L.D. Yee, and K.K. Chan Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice Cancer Chemother. Pharmacol. 69 2012 679 689
12. R. Jäger, R.P. Lowery, A.V. Calvanese, J.M. Joy, M. Purpura, and J.M. Wilson Comparative absorption of curcumin formulations Nutr. J. 13 2014 11
13. L. Ma'mani, S. Nikzad, H. Kheiri-Manjili, S. Al-Musawi, M. Saeedi, and S. Askarlou Foroumadi A1, shafiee A, curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy Eur. J. Med. Chem. 83 2014 646 654
14. Y.M. Tsai, W.L. Chang-Liao, C.F. Chien, L.C. Lin, and T.H. Tsai Effects of polymer molecular weight on relative oral bioavailability of curcumin Int. J. Nanomedicine 7 2012 2957 2966
15. O. Naksuriya, S. Okonogi, R.M. Schiffelers, and W.E. Hennink Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment Biomaterials 35 2014 3365 3383
16. F. Balas, M. Manzano, P. Horcajada, and M. Vallet-Regi Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials J. Am. Chem. Soc. 128 2006 8116 8117
17. L. Li, F. Tang, H. Liu, T. Liu, N. Hao, D. Chen, X. Teng, and J. He In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy ACS Nano 4 2010 6874 6882
18. X. Xue, M.D. Hall, Q. Zhang, P.C. Wang, M.M. Gottesman, and X.J. Liang Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking ACS Nano 7 2013 10452 10464
19. S. Jambhrunkar, S. Karmakar, A. Popat, M.H. Yu, and C.Z. Yu Mesoporous silica nanoparticles enhance the cytotoxicity of curcumin RSC Adv. 4 2014 709 712
20. P. Yang, S. Gai, and J. Lin Functionalized mesoporous silica materials for controlled drug delivery Chem. Soc. Rev. 41 2012 3679 3698
21. I.I. Slowing, J.L. Vivero-Escoto, C.-W. Wu, and V.S.-Y. Lin Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers Adv. Drug Deliv. Rev. 60 2008 1278 1288
22. C. Fu, T. Liu, L. Li, H. Liu, D. Chen, and F. Tang The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes Biomaterials 34 2013 2565 2575
23. Q. He, Z. Zhang, F. Gao, Y. Li, and J. Shi In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation Small 7 2011 271 280
24. J.-H. Park, L. Gu, G. von Maltzahn, E. Ruoslahti, S.N. Bhatia, and M.J. Sailor Biodegradable luminescent porous silicon nanoparticles for in vivo applications Nat. Mater. 8 2009 331 336
25. J. Lu, M. Liong, Z. Li, J.I. Zink, and F. Tamanoi Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals Small 6 2010 1794 1805
26. T. Liu, L. Li, X. Teng, X. Huang, H. Liu, D. Chen, J. Ren, J. He, and F. Tang Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice Biomaterials 32 2011 1657 1668
27. R. Kotcherlakota, A.K. Barui, S. Prashar, M. Fajardo, D. Briones, A. Rodríguez-Diéguez, C.R. Patra, and S. Gómez-Ruiz Curcumin loaded mesoporous silica: an effective drug delivery system for cancer treatment Biomater Sci. 4 2016 448 459
28. M. Manzano, V. Aina, C.O. Areán, F. Balas, V. Cauda, M. Colilla, M.R. Delgadob, and M. Vallet-Regí Studies on MCM-41 mesoporous silica for drug delivery: effect of particle morphology and amine functionalization Chem. Eng. J. 15 2008 30 37
29. N. Hao, K.W. Jayawardana, X. Chen, and M. Yan One-step synthesis of amine-functionalized hollow mesoporous silica nanoparticles as efficient antibacterial and anticancer materials ACS Appl. Mater. Interfaces 7 2015 1040 1045
30. K.M. Kim, H.M. Kim, W.J. Lee, C.W. Lee, T.I. Kim, J.K. Lee, J. Jeong, S.M. Paek, and J.M. Oh Surface treatment of silica nanoparticles for stable and charge-controlled colloidal silica Int. J. Nanomedicine 9 2014 29 40
31. S. Sánchez-Muñoz, S. Gómez-Ruiz, D. Pérez-Quintanilla, S. Morante-Zarcero, I. Sierra, S. Prashar, R. Paschke, and G.N. Kaluderović Preliminary study of the anticancer applications of mesoporous materials functionalized with the natural product betulinic acid ChemMedChem 7 2012 670 679
32. D. Perez-Quintanilla, A. Sanchez, I. del Hierro, M. Fajardo, and I. Sierra Synthesis and characterization of novel mesoporous silicas of the MSU-X family for environmental applications J. Nanosci. Nanotechnol. 9 2009 4901 4909
33. M.V. Landau, S.P. Varkey, M. Herskowitz, O. Regev, S. Pevzner, T. Sen, and Z. Luz Wetting stability of Si-MCM-41 mesoporous material in neutral, acidic and basic aqueous solutions Microporous Mesoporous Mater. 33 1999 149 163
34. P. Horcajada, A. Ramila, J. Perez-Pariente, and M. Vallet-Regí Influence of pore size of MCM-41 matrices on drug delivery rate Microporous Mesoporous Mater. 68 2004 105 109
35. N.R. Chereddy, K. Saranraj, S. Thennarasu, A.K. Barui, C.R. Patra, and V.J. Rao Donor atom selective coordination of Fe3 + and Cr3 + trigger fluorophore specific emission in a rhodamine-naphthalimide dyad RSC Adv. 4 2014 24324 24327
36. A. Modak, A.K. Barui, C.R. Patra, and A. Bhaumik A luminescent nanoporous hybrid material based drug delivery system showing excellent theranostics potential for cancer Chem. Commun. (Camb.) 49 2013 7644 7646
37. T. Gayathri, A.K. Barui, S. Prashanthi, C.R. Patra, and S.P. Singh Meso-substituted BODIPY fluorescent probes for cellular bio-imaging and anticancer activity RSC Adv. 4 2014 47409 47413
38. P. Nagababu, A.K. Barui, B. Thulasiram, C.S. Devi, S. Satyanarayana, and C.R. Patra Sreedhar B antiangiogenic activity of mononuclear copper(II) polypyridyl complexes for the treatment of cancers J. Med. Chem. 58 2015 5226 52241
39. S. Mukherjee, D. Chowdhury, R. Kotcherlakota, S,.B.V. Patra, M.P. Bhadra, B. Sreedhar, and C.R. Patra Potential theranostics application of bio-synthesized silver nanoparticles (4-in-1 system) Theranostics 4 2014 316 335
40. K.S.W. Sing, D.H. Everett, R.A.W. Haul, L. Moscou, Pierotti RA, J. Rouquerol, and T. Siemieniewska Reporting physisorption data for gas-solid systems with special reference to the determination of surface-area and porosity Pure Appl. Chem. 57 1985 603 619
41. G. Engelhardt, and D. Michel High Resolution Solid-State NMR of Silicate and Zeolites 1987 John Wiley & Sons Chichester 485 (xiv)
42. F. Tang, L. Li, and D. Chen Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery Adv. Mater. 24 2012 1504 1534
43. Q.J. He, and J.L. Shi Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility J. Mater. Chem. 21 2011 5845 5855
44. G.N. Kaluderovic, D. Pérez-Quintanilla, I. Sierra, S. Prashar, I. Hierro, Ž. Žižak, Z.D. Juranić, M. Fajardo, and S. Gómez-Ruiz Study of the influence of the metal complex on the cytotoxic activity of titanocene-functionalized mesoporous materials J. Mater. Chem. 20 2010 806 814
45. G.N. Kaluderovic, D. Perez-Quintanilla, Z. Zizak, and Z.D. Juranic Gomez-Ruiz S Improvement of cytotoxicity of titanocene-functionalized mesoporous materials by the increase of the titanium content Dalton Trans. 39 2010 2597 2608
46. J. Ceballos-Torres, P. Virag, M. Cenariu, S. Prashar, M. Fajardo, E. Fischer-Fodor, and S. Gómez-Ruiz Anti-cancer applications of titanocene-functionalised nanostructured systems: an insight into cell death mechanisms Chem. Eur. J. 20 2014 10811 10828
47. M.Z. Bulatović, D. Maksimović-Ivanić, C. Bensing, S. Gómez-Ruiz, D. Steinborn, H. Schmidt, M. Mojić, A. Korać, I. Golić, D. Pérez-Quintanilla, M. Momčilović, S. Mijatović, and G.N. Kaluderović Organotin(IV)-loaded mesoporous silica as a biocompatible strategy in cancer treatment Angew. Chem. 53 2014 5982 5987
48. A.J. Di Pasqua, K.K. Sharma, Y.L. Shi, B.B. Toms, W. Ouellette, J.C. Dabrowiak, and T. Asefa Cytotoxicity of mesoporous silica nanomaterials J. Inorg. Biochem. 102 2008 1416 1422
49. Z. Tao, B.B. Toms, J. Goodisman, and T. Asefa Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials Chem. Res. Toxicol. 22 2009 1869 1880
50. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discov. 9 2010 615 627
51. Y. Sanchez, G.P. Simon, E. Calvino, E. de Blas, and P. Aller Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines J. Pharmacol. Exp. Ther. 335 2010 114 123
52. S. Pattingre, A. Tassa, X. Qu, R. Garuti, X.H. Liang, N. Mizushima, M. Packer, M.D. Schneider, and B. Levine Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy Cell 122 2005 927 939
53. T. Högnason, S. Chatterjee, T. Vartanian, R.R. Ratan, K.M. Ernewein, and A.A. Habib Epidermal growth factor receptor induced apoptosis: potentiation by inhibition of Ras signaling FEBS Lett. 491 2001 9 15
54. J. Rao, D.R. Xu, F.M. Zheng, Z.J. Long, S.S. Huang, X. Wu, W.H. Zhou, R.W. Huang, and Q. Liu Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34 + acute myeloid leukemia cell lines and primary sorted CD34 + acute myeloid leukemia cells J. Transl. Med. 9 2011 71
55. S. Lev-Ari, A. Starr, A. Vexler, V. Karaush, V. Loew, J. Greif, E. Fenig, D. Aderka, and R. Ben-Yosef Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity Anticancer Res. 26 2006 4423 4430